Document Detail

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.
MedLine Citation:
PMID:  23407226     Owner:  NLM     Status:  In-Data-Review    
SETTING: The Republic of Moldova, in Eastern Europe, has among the highest reported nationwide proportions of tuberculosis (TB) patients with multidrug-resistant tuberculosis (MDR-TB) worldwide. Default has been associated with increased mortality and amplification of drug resistance, and may contribute to the high MDR-TB rates in Moldova.
OBJECTIVE: To assess risk factors and timing of default from treatment for non-MDR-TB from 2007 to 2010.
DESIGN: A retrospective analysis of routine surveillance data on all non-MDR-TB patients reported.
RESULTS: A total of 14.7% of non-MDR-TB patients defaulted from treatment during the study period. Independent risk factors for default included sociodemographic factors, such as homelessness, living alone, less formal education and spending substantial time outside Moldova in the year prior to diagnosis; and health-related factors such as human immunodeficiency virus co-infection, greater lung pathology and increasing TB drug resistance. Anti-tuberculosis treatment is usually initiated within an institutional setting in Moldova, and the default risk was highest in the month following the phase of hospitalized treatment (among civilians) and after leaving prison (among those diagnosed while incarcerated).
CONCLUSIONS: Targeted interventions to increase treatment adherence for patients at highest risk of default, and improving the continuity of care for patients transitioning from institutional to community care may substantially reduce risk of default.
H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Related Documents :
23814466 - Health-related quality of life in dialysis patients with constipation: a cross-sectiona...
24083646 - Elevated cardiac troponin t levels in critically ill patients with sepsis.
23407226 - Risk factors and timing of default from treatment for non-multidrug-resistant tuberculo...
23616916 - The efficacy and safety of romiplostim in adult patients with chronic immune thrombocyt...
24067436 - Reading between the (guide)lines-the kdigo practice guideline on acute kidney injury in...
2171296 - Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid the...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  17     ISSN:  1815-7920     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  373-80     Citation Subset:  IM    
Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in S...
Next Document:  Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continent...